Current Medical Management of Peptic Ulcer Disease
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Peptic ulceration occurs when the digestive action of gastric secretions overcomes gastroduodenal mucosal defences. The therapeutic strategy used to correct this imbalance uses drugs that either reduce gastric secretion or increase mucosal resistance. Traditional therapies of dietary manipulation and antacid administration no longer play major roles in peptic ulcer therapy. Uncomplicated peptic ulcers respond quite well to drug treatment, although recurrences are common and may require long-term maintenance therapy. Drug-induced gastric ulcers have represented a challenging problem, for which effective therapy is now available.
References
1.
Berstad A, Weberg R
. Antacids in the treatment of gastroduodenal ulcer. Scand J Gastroenterol. 1986; 21(4):385-91.
DOI: 10.3109/00365528609015152.
View
2.
Pounder R
. Silent peptic ulceration: deadly silence or golden silence?. Gastroenterology. 1989; 96(2 Pt 2 Suppl):626-31.
DOI: 10.1016/s0016-5085(89)80058-7.
View
3.
Gudjonsson B, Spiro H
. Response to placebos in ulcer disease. Am J Med. 1978; 65(3):399-402.
DOI: 10.1016/0002-9343(78)90761-1.
View
4.
Ippoliti A, Elashoff J, Valenzuela J, Cano R, Frankl H, Samloff M
. Recurrent ulcer after successful treatment with cimetidine or antacid. Gastroenterology. 1983; 85(4):875-80.
View
5.
Graham D
. Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy. Gastroenterology. 1989; 96(2 Pt 2 Suppl):675-81.
DOI: 10.1016/s0016-5085(89)80064-2.
View